Yvonne joined Portola nearly eight years ago following graduate school. As a pharmacokinetic scientist, she supports the discovery and development of Portola’s cardiovascular and anti-inflammatory drug candidates. Among her achievements is being part of a team that selected two clinical drug candidates that moved forward to an IND. Yvonne prides herself on her ability to adapt to any situation, an attribute that is important to have in the fast-paced, dynamic and challenging environment at Portola. “At Portola I am a part of a common cause. My work truly contributes to achieving the ultimate goal of treating patients with cardiovascular and inflammatory diseases and providing a better quality of life for them.”Athiwat Hutchaleelaha, Ph.D.
An employee of Portola since its inception more than eight years ago, Athiwat leads the Drug Metabolism and Pharmacokinetics department. In that role, he supports the drug discovery and development of cardiovascular and anti-inflammatory drug candidates. He has conducted several key studies that have led to the selection and development of Portola’s two most advanced clinical lead candidates. A seasoned research scientist with experience in pharmacokinetics and drug metabolism at both large and small pharmaceutical companies, Athiwat enjoys Portola’s working environment and culture. “At Portola, each individual is made to feel a critical part of the company. Everyone is dedicated and works tirelessly to bring better medications to patients in need.”